YihongWangMDPhD

Pathology • Providence, RI

Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology, Albert Einstein College of Medicine

Join to view full profile

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

Office
593 Eddy St
Apc 12
Providence, RI 02903
Phone+1 401-444-9897

Fax+1 401-444-8514

Education & Training

Beth Israel Deaconess Medical Center/Harvard Medical School Breast PathologyFellowship, Selective Pathology, 2008 - 2009
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 2004 - 2008
Shandong Medical UniversityClass of 1994

Certifications & Licensure

RI State Medical License 2012 - 2026
NY State Medical License 2009 - 2013
American Board of Pathology Pathology - Anatomic

Publications & Presentations

PubMed

Is Axillary Lymph Node Dissection Needed? Clinicopathological Correlation in a Series of 224 Neoadjuvant Chemotherapy-Treated Node-Positive Breast Cancers.
Sean M Hacking, Dongling Wu, Charu Taneja, Theresa Graves, Liang Cheng
Clinical Breast Cancer. 2025-02-01
Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study.
Thomas E Rohan, Yihong Wang, Fergus Couch, Heather Spencer Feigelson, Robert T Greenlee
Breast Cancer Research and Treatment. 2025-01-20
Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry.
Maryam Tahir, Deyin Xing, Qingqing Ding, Yihong Wang, Kamaljeet Singh
Histopathology. 2025-01-01

Journal Articles

In Reply to Dr. Lambein Et Al “HER2 Protein Overexpression in Non‐Amplified Ductal Carcinoma in Situ: Quality Issue or Transcription Mechanisms Gone Awry?”
Yiang Hui, Yihong Wang, Murray B Resnick, Histopathology
Discordant HER2 Immunohistochemical Expression and Gene Amplification in Ductal Carcinoma in Situ ‐ Evaluating HER2 in Synchronous in Situ and Invasive Carcinoma
Yiang Hui, Shaolei Lu, Murray B Resnick, Yihong Wang, Histopathology